Skip to main content
. 2023 Mar 18;252:115292. doi: 10.1016/j.ejmech.2023.115292

Table 1.

The anti-SARS-CoV-2 properties of Galidesivir against different cell cultures.

Cell line SARS-CoV-2 strains Assay Incubation period EC50 (μM) EC90 (μM) CC50 (μM) SI
Caco-2 WA1/2020 VYRa 24 h n.d.b 14.19 82.8 5.8
Vero-76 WA1/2020 VYRa 24 h n.d.b 10.94 >295.7 >27
CPEc 50.3 5.8
Calu-3 WA1/2020 Imaging 2 h 14.15 n.d. >50 >3.5
a

VYR = Viral Yield Reduction.

b

n.d. = not determined.

c

CPE = cytopathic effect.